9rules - The best content from the independent web.

Browse 9rules By - Great blogs sorted by topic at 9rules.

Pharma Strategy Blog By Sally Church

Member Since 2009 of the Science Community

Recent Posts

The role of the Androgen Receptor in breast cancer »

Posted Feb 10, 2012

Is ARN-509 (Aragon) potentially better than MDV-3100 (Medivation) in advanced prostate cancer? »

Posted Feb 02, 2012

Update on Medivation’s MDV3100 in advanced prostate cancer »

Posted Jan 31, 2012

On KRAS, NF-kB activation and pancreatic cancer »

Posted Jan 31, 2012

FDA approves Roche hedgehog inhibitor vismodegib/Erivedge in basal cell carcinoma »

Posted Jan 30, 2012

A new opportunity for vemurafenib in BRAFV600E colon cancer »

Posted Jan 26, 2012

Unravelling early colorectal cancer: the links between ROS, DNA methylation and inflammatory responses »

Posted Jan 24, 2012

New research demonstrates the link between inflammation and early development of colon cancer »

Posted Jan 23, 2012

RNAi as a potential biomarker for early breast cancer »

Posted Jan 16, 2012

Gene mutation and resistance to chemotherapy in colorectal cancer »

Posted Jan 05, 2012

ASH 2011 Update #3 – Multiple Myeloma »

Posted Jan 04, 2012

AVEO announces front-line data in renal cell cancer for tivozanib »

Posted Jan 03, 2012

ASH 2011 Update #2 – Non Hodgkins Lymphoma »

Posted Dec 21, 2011

ASH 2011 Update 1: Bruton’s Kinase Inhibitors (BTK) »

Posted Dec 15, 2011

What’s hot at SABCS – Update 2 – advanced breast cancer »

Posted Dec 10, 2011

Follow the American Society of Hematology ASH conversations! »

Posted Dec 10, 2011

What’s hot at the American Society of Hematology 2011? »

Posted Dec 09, 2011

What’s hot at SABCS – Update 1 »

Posted Dec 08, 2011

Video preview of San Antonio Breast Cancer Symposium 2011 »

Posted Dec 07, 2011

Follow the conversation from 2011 San Antonio Breast Cancer Symposium »

Posted Dec 06, 2011